DD296489A5 - Substituierte 2-imidiazol und verfahren und verwendung - Google Patents

Substituierte 2-imidiazol und verfahren und verwendung Download PDF

Info

Publication number
DD296489A5
DD296489A5 DD90342726A DD34272690A DD296489A5 DD 296489 A5 DD296489 A5 DD 296489A5 DD 90342726 A DD90342726 A DD 90342726A DD 34272690 A DD34272690 A DD 34272690A DD 296489 A5 DD296489 A5 DD 296489A5
Authority
DD
German Democratic Republic
Prior art keywords
alkyl
pyridyl
alkoxy
chlorine
fluorine
Prior art date
Application number
DD90342726A
Other languages
German (de)
English (en)
Inventor
Poul Borrevang
Henrik S Andersen
Original Assignee
����`�������@�a�k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ����`�������@�a�k�� filed Critical ����`�������@�a�k��
Publication of DD296489A5 publication Critical patent/DD296489A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Fertilizers (AREA)
  • Lubricants (AREA)
  • Nonmetallic Welding Materials (AREA)
  • External Artificial Organs (AREA)
DD90342726A 1989-07-12 1990-07-12 Substituierte 2-imidiazol und verfahren und verwendung DD296489A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK344489A DK344489D0 (da) 1989-07-12 1989-07-12 Substituerede 2-imidazoliner og fremstilling og anvendelse deraf

Publications (1)

Publication Number Publication Date
DD296489A5 true DD296489A5 (de) 1991-12-05

Family

ID=8122944

Family Applications (1)

Application Number Title Priority Date Filing Date
DD90342726A DD296489A5 (de) 1989-07-12 1990-07-12 Substituierte 2-imidiazol und verfahren und verwendung

Country Status (22)

Country Link
US (1) US5262430A (ko)
EP (1) EP0482108B1 (ko)
JP (1) JPH04506968A (ko)
KR (1) KR927003578A (ko)
CN (1) CN1049343A (ko)
AT (1) ATE135703T1 (ko)
AU (1) AU637393B2 (ko)
CA (1) CA2064095A1 (ko)
DD (1) DD296489A5 (ko)
DE (1) DE69026087T2 (ko)
DK (2) DK344489D0 (ko)
ES (1) ES2086409T3 (ko)
FI (1) FI920118A0 (ko)
GR (1) GR1000716B (ko)
IE (1) IE74210B1 (ko)
IL (1) IL95046A (ko)
NO (1) NO920143L (ko)
NZ (1) NZ234451A (ko)
PT (1) PT94685B (ko)
WO (1) WO1991000862A1 (ko)
YU (1) YU136390A (ko)
ZA (1) ZA905422B (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4201709A1 (de) * 1992-01-23 1993-07-29 Bayer Ag (alpha)-aryl-(alpha)-hydroxy-ss-imidazolinyl-propionsaeureamide
US5750543A (en) * 1996-02-01 1998-05-12 The Procter & Gamble Company Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
US6410562B1 (en) 1998-12-18 2002-06-25 Eli Lilly And Company Hypoglycemic imidazoline compounds
US20090162342A1 (en) * 2001-06-07 2009-06-25 Sanomune Inc. Therapeutic uses of glandular kallikrein
AU2005250116B2 (en) * 2004-06-01 2011-01-20 F. Hoffmann-La Roche Ag 3-amino-1-arylpropyl indoles as monoamine reuptake inhibitor
US20130315891A1 (en) 2012-05-25 2013-11-28 Matthew Charles Formulations of human tissue kallikrein-1 for parenteral delivery and related methods
HUE032613T2 (en) 2012-06-04 2017-10-30 Diamedica Therapeutics Inc Human tissue kallikrein 1 is glycosylated isoforms
AU2018230478A1 (en) 2017-03-09 2019-09-12 Diamedica Inc. Dosage forms of tissue kallikrein 1

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5936885B2 (ja) * 1976-06-24 1984-09-06 第一製薬株式会社 糖尿病治療剤
NZ201219A (en) * 1981-07-28 1984-10-19 Reckitt & Colmann Prod Ltd Dihydrobenzofuranyl-2-imidazolines and pharmaceutical compositions
GB2167408B (en) * 1984-11-23 1988-05-25 Farmos Oy Substituted imidazole derivatives and their preparation and use

Also Published As

Publication number Publication date
YU136390A (sh) 1993-10-20
IL95046A0 (en) 1991-06-10
PT94685B (pt) 1997-04-30
WO1991000862A1 (en) 1991-01-24
GR900100535A (en) 1991-12-10
CA2064095A1 (en) 1991-01-13
DE69026087D1 (de) 1996-04-25
IE902546A1 (en) 1991-02-27
KR927003578A (ko) 1992-12-18
NO920143L (no) 1992-03-04
ATE135703T1 (de) 1996-04-15
DK0482108T3 (da) 1996-07-22
AU637393B2 (en) 1993-05-27
EP0482108B1 (en) 1996-03-20
AU6164490A (en) 1991-02-06
GR1000716B (el) 1992-11-23
NZ234451A (en) 1991-08-27
CN1049343A (zh) 1991-02-20
NO920143D0 (no) 1992-01-10
DE69026087T2 (de) 1996-08-29
FI920118A0 (fi) 1992-01-10
IE74210B1 (en) 1997-07-16
ES2086409T3 (es) 1996-07-01
ZA905422B (en) 1991-03-27
IL95046A (en) 1995-03-15
EP0482108A1 (en) 1992-04-29
JPH04506968A (ja) 1992-12-03
PT94685A (pt) 1991-03-20
DK344489D0 (da) 1989-07-12
US5262430A (en) 1993-11-16

Similar Documents

Publication Publication Date Title
DE3871916T2 (de) Thiazolidindione als hypoglykaemische und antiatherosklerotische mittel.
DE68905639T2 (de) Hypoglykaemische thiazolidindion-derivate.
DE3129309C2 (ko)
DE69015587T2 (de) Hypoglykämische Oxazolidindion-Derivate.
DE69907210T2 (de) Glucocorticoid- und thyroidhormonrezeptor-liganden zur behandlung von stoffwechselkrankheiten
DE60315603T2 (de) Modulatoren von peroxisome proliferator-aktivierten rezeptoren
DE60029446T2 (de) Arylthiazolidindione und aryloxazolidindion-derivate
DE69106714T2 (de) Hypoglykämische hydroxyharnstoffderivate.
US4595693A (en) Method of use of 2,5-diaryl tetrahydrofurans and analogs thereof as PAF-antagonists
DE69721134T2 (de) Verfahren zur Herstellung von 4-(2-(2-Pyridyl)Ethoxy)Benzaldehyd-Derivate
DE3875073T2 (de) 3-(4(1-substituierte-4-piperazinyl)butyl)-4-thiazolidinone, verfahren zu deren herstellung und ihre anwendung als arzneimittel.
DE60210784T2 (de) Orale antidiabetische wirkstoffe
DE602005002647T2 (de) Hexensäurederivate, verfahren zu deren herstellung, pharmazeutische zusammensetzungen, die diese enthalten, und therapeutische anwendungen davon
DD261154A5 (de) Verfahren zur herstellung einer hypoglykaemisch wirksamen thiozolidindion-verbindung
DE69836980T2 (de) Arylthiazolidindion-derivate
DE2915037A1 (de) Neue n-substituierte moranolinderivate
DE3788982T2 (de) Trans-6-[2-(N-heteroaryl)-3,5-disubstituiertes)pyrazol-4-yl)-ethyl] oder -ethenyl]tetrahydro-4-hydroxypyran-2-on-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung.
DE2933441A1 (de) Neue spiro-oxazolidindione und solche verbindungen enthaltende arzneimittel
DE69204041T2 (de) Thiazolidinverbindeungen, deren Herstellung und therapeutische Verwendung.
DE60015390T9 (de) Antidiabetische thiazolidindione und ihre herstellung
DE69018876T2 (de) Pyridazinon-Derivate.
EP0025192A2 (de) Substituierte Oxirancarbonsäuren, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende Arzneimittel
DD296489A5 (de) Substituierte 2-imidiazol und verfahren und verwendung
DE3041097A1 (de) Substituierte oxocarbonsaeuren, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende arzneimittel
EP0030632B1 (de) Benzothiazolderivate, diese enthaltende pharmazeutische Zubereitungen und Verfahren zu ihrer Herstellung

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee